Madison Carlino
Policy Analyst, Reason Foundation
Madison S. Carlino is a policy analyst at Reason Foundation. Her work primarily focuses on drug policy in the United States, including psychedelic medicine and marijuana laws.
Before joining Reason, Carlino worked as a research intern and grant writer with the James Madison Institute in Tallahassee, where she focused on education policies that empower Florida parents to choose schools, courses, resources, and programs that fit their child's unique needs, interests, and learning styles. Her research also emphasized the role of constitutional rights in promoting democracy and freedom.
As an undergraduate, Carlino was a policy analyst at Florida State University's DeVoe L. Moore Center. During her tenure there, she developed and conducted a research project examining the relationship between Cuban enclaves and Cuban wages in Miami.
Carlino graduated summa cum laude with a B.S. in economics from Florida State University, where she double-majored in economics and media/communication studies with a minor in business.
-
Florida’s attorney general challenges marijuana initiative with spurious arguments
Florida voters have the chance to vote on a marijuana ballot initiative, but Florida politicians are trying to keep that from happening.
-
Survey shows stereotype of the lazy, lefty marijuana smoker doesn’t reflect reality
Marijuana users come from all different backgrounds and are not restricted to a particular political affiliation, education level, income bracket, career position, or location.
-
The Breakthrough Therapies Act could spur research and improve access to life-saving drugs
The Breakthrough Therapies Act would pave the way for more accessible and innovative mental health treatments while also enabling state-level adaptation.
-
The long road to Kentucky’s limited medical marijuana legalization
Participants in the new Kentucky medical program will face limitations not typically found in most states, including a continued ban on smoking marijuana.
-
Research showing the tremendous therapeutic potential of psychedelics
In clinical trials, one-third of patients who showed no response to at least two other forms of treatment for depression demonstrated lasting remission following a single treatment with psilocybin.
-
Federal legislation to protect Second Amendment rights of legal cannabis users
The GRAM Act would ensure that individuals are not forced to choose between exercising their constitutional rights to own a gun and legally using cannabis.
-
The latest on proposed psychedelics legalization in states
Pending legislation across roughly a dozen states signals that this shift toward the legalization of psychedelic therapies may continue.
-
Federal judge: Restrictions on gun ownership violate medical marijuana patients’ Second Amendment rights
Federal firearm policy should not discriminate against users of medical marijuana.